Fig. 2From: EFFECT: a randomized phase II study of efficacy and impact on function of two doses of nab-paclitaxel as first-line treatment in older women with advanced breast cancerKaplan-Meier analysis of event-free survival by treatment arm: investigator reported (a) and at central review (b)Back to article page